• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过微阵列分析鉴定出的8种在糖尿病肾病中具有差异的微小RNA作为新型生物标志物

Eight Differential miRNAs in DN Identified by Microarray Analysis as Novel Biomarkers.

作者信息

Tu Chao, Wei Lan, Wang Liangzhi, Tang Ying

机构信息

Department of Internal Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, People's Republic of China.

Department of Rehabilitation Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, 213000, People's Republic of China.

出版信息

Diabetes Metab Syndr Obes. 2022 Mar 24;15:907-920. doi: 10.2147/DMSO.S355783. eCollection 2022.

DOI:10.2147/DMSO.S355783
PMID:35359345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8961165/
Abstract

BACKGROUND

Diabetic nephropathy (DN) is the common cause of renal diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD). Various diagnostic applications and treatment methods are used for clinical but remain some prognosis issues. To avoid morbidity and mortality related to DN, early detection of disease complications as well as targeted therapeutic strategies is essential. Considerable evidence indicates that non-coding RNA plays a vital role in the biological processes of various diseases, used as biomarkers and therapeutic targets. And the most known ncRNAs are the microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs).

MATERIALS AND METHODS

Our study aimed to identify potential prognostic ncRNAs involved in DN by bioinformatics analysis and validated expression levels through quantitative polymerase chain reaction (qPCR) and GEO database. Our research focuses on differential expression miRNAs (DEmiRNAs) in DN and their interactions with critical genes.

RESULTS

We identified 8 up-regulated DEmiRNAs, including miR-103a-2-5p, miR-297, miR-548x-3p, miR-604, miR-644a, miR-1256, miR-3911 and miR-5047 finally. We further validated these miRNAs in a murine model.

CONCLUSION

Identifying these up-regulated genes and elucidating these miRNAs regulatory network will contribute to a better understanding of the molecular mechanism of DN and how they can be used as new biomarkers and potential therapeutic targets for DN.

摘要

背景

糖尿病肾病(DN)是终末期肾病(ESRD)和慢性肾脏病(CKD)等肾脏疾病的常见病因。临床上使用了各种诊断应用和治疗方法,但仍存在一些预后问题。为避免与DN相关的发病率和死亡率,早期发现疾病并发症以及有针对性的治疗策略至关重要。大量证据表明,非编码RNA在各种疾病的生物学过程中起着至关重要的作用,可作为生物标志物和治疗靶点。最知名的非编码RNA是微小RNA(miRNA)、长链非编码RNA(lncRNA)和环状RNA(circRNA)。

材料与方法

我们的研究旨在通过生物信息学分析鉴定参与DN的潜在预后性非编码RNA,并通过定量聚合酶链反应(qPCR)和GEO数据库验证其表达水平。我们的研究重点是DN中差异表达的miRNA(DEmiRNA)及其与关键基因的相互作用。

结果

我们最终鉴定出8种上调的DEmiRNA,包括miR-103a-2-5p、miR-297、miR-548x-3p、miR-604、miR-644a、miR-1256、miR-3911和miR-5047。我们在小鼠模型中进一步验证了这些miRNA。

结论

鉴定这些上调基因并阐明这些miRNA调控网络将有助于更好地理解DN的分子机制,以及它们如何用作DN的新生物标志物和潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d8/8961165/732ae05aa3d3/DMSO-15-907-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d8/8961165/893bf615254a/DMSO-15-907-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d8/8961165/e62c9385af12/DMSO-15-907-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d8/8961165/899adeed446c/DMSO-15-907-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d8/8961165/c3355023bf5a/DMSO-15-907-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d8/8961165/7e0f9dae3b1a/DMSO-15-907-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d8/8961165/732ae05aa3d3/DMSO-15-907-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d8/8961165/893bf615254a/DMSO-15-907-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d8/8961165/e62c9385af12/DMSO-15-907-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d8/8961165/899adeed446c/DMSO-15-907-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d8/8961165/c3355023bf5a/DMSO-15-907-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d8/8961165/7e0f9dae3b1a/DMSO-15-907-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d8/8961165/732ae05aa3d3/DMSO-15-907-g0006.jpg

相似文献

1
Eight Differential miRNAs in DN Identified by Microarray Analysis as Novel Biomarkers.通过微阵列分析鉴定出的8种在糖尿病肾病中具有差异的微小RNA作为新型生物标志物
Diabetes Metab Syndr Obes. 2022 Mar 24;15:907-920. doi: 10.2147/DMSO.S355783. eCollection 2022.
2
Interactions Among Non-Coding RNAs in Diabetic Nephropathy.糖尿病肾病中非编码RNA之间的相互作用
Front Pharmacol. 2020 Mar 3;11:191. doi: 10.3389/fphar.2020.00191. eCollection 2020.
3
Complement C7 is Specifically Expressed in Mesangial Cells and is a Potential Diagnostic Biomarker for Diabetic Nephropathy and is Regulated by miR-494-3p and miR-574-5p.补体C7在系膜细胞中特异性表达,是糖尿病肾病的潜在诊断生物标志物,并受miR-494-3p和miR-574-5p调控。
Diabetes Metab Syndr Obes. 2021 Jul 5;14:3077-3088. doi: 10.2147/DMSO.S311725. eCollection 2021.
4
Dysregulated Urinary Extracellular Vesicle Small RNAs in Diabetic Nephropathy: Implications for Diagnosis and Therapy.糖尿病肾病中尿细胞外囊泡小RNA的失调:对诊断和治疗的意义
J Endocr Soc. 2024 Jun 12;8(8):bvae114. doi: 10.1210/jendso/bvae114. eCollection 2024 Jul 1.
5
Intrarenal microRNA signature related to the fibrosis process in chronic kidney disease: identification and functional validation of key miRNAs.与慢性肾脏病纤维化过程相关的肾内 microRNA 特征:关键 microRNA 的鉴定和功能验证。
BMC Nephrol. 2019 Aug 27;20(1):336. doi: 10.1186/s12882-019-1512-x.
6
Microarray analysis of long noncoding RNA expression patterns in diabetic nephropathy.糖尿病肾病中长链非编码RNA表达模式的微阵列分析
J Diabetes Complications. 2017 Mar;31(3):569-576. doi: 10.1016/j.jdiacomp.2016.11.017. Epub 2016 Dec 8.
7
Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy.尿 microRNA-27b-3p 和 microRNA-1228-3p 与糖尿病肾病肾纤维化的进展相关。
Sci Rep. 2019 Aug 6;9(1):11357. doi: 10.1038/s41598-019-47778-1.
8
Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy.环状 RNA;克服糖尿病肾病的强大 microRNA 海绵。
Pathol Res Pract. 2021 Nov;227:153618. doi: 10.1016/j.prp.2021.153618. Epub 2021 Sep 15.
9
Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy.鉴定糖尿病肾病相关的铜生物标志物及潜在分子机制
Front Endocrinol (Lausanne). 2022 Oct 18;13:978601. doi: 10.3389/fendo.2022.978601. eCollection 2022.
10
Long non-coding RNA HCP5 serves as a ceRNA sponging miR-17-5p and miR-27a/b to regulate the pathogenesis of childhood obesity via the MAPK signaling pathway.长链非编码RNA HCP5作为一种竞争性内源RNA,通过海绵吸附miR-17-5p和miR-27a/b,经由丝裂原活化蛋白激酶信号通路调控儿童肥胖的发病机制。
J Pediatr Endocrinol Metab. 2019 Dec 18;32(12):1327-1339. doi: 10.1515/jpem-2018-0432.

引用本文的文献

1
Identification of the miRNAome in human fracture callus and nonunion tissues.人骨折痂和骨不连组织中微小RNA组的鉴定。
J Orthop Translat. 2023 Mar 1;39:113-123. doi: 10.1016/j.jot.2023.01.005. eCollection 2023 Mar.

本文引用的文献

1
Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease.早期糖尿病肾病中 TNF 受体与 KIM-1 与肾脏结局的关系。
Clin J Am Soc Nephrol. 2022 Feb;17(2):251-259. doi: 10.2215/CJN.08780621. Epub 2021 Dec 7.
2
Silencing of MicroRNA-503 in Rat Mesenchymal Stem Cells Exerts Potent Antitumorigenic Effects in Lung Cancer Cells.大鼠间充质干细胞中MicroRNA-503的沉默对肺癌细胞具有强大的抗肿瘤作用。
Onco Targets Ther. 2021 Jan 6;14:67-81. doi: 10.2147/OTT.S282322. eCollection 2021.
3
The lncRNA Functions as a ceRNA for to Suppress Osteosarcoma by Regulating the Expression of .
长链非编码RNA作为竞争性内源RNA,通过调控……的表达来抑制骨肉瘤。 (注:原文中“for to”表述有误,推测应是“for...”,这里按推测后的情况翻译,具体需根据正确原文进一步准确翻译)
Onco Targets Ther. 2020 Dec 24;13:13171-13181. doi: 10.2147/OTT.S266435. eCollection 2020.
4
Long Noncoding RNA LINC00963 Promotes CDC5L-Mediated Malignant Progression in Gastric Cancer.长链非编码RNA LINC00963促进CDC5L介导的胃癌恶性进展
Onco Targets Ther. 2020 Dec 22;13:12999-13013. doi: 10.2147/OTT.S274708. eCollection 2020.
5
Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs.利用微小RNA靶向治疗糖尿病肾病中的肾纤维化
Front Pharmacol. 2020 Nov 13;11:587689. doi: 10.3389/fphar.2020.587689. eCollection 2020.
6
LncRNA MIR503HG Promotes High-Glucose-Induced Proximal Tubular Cell Apoptosis by Targeting miR-503-5p/Bcl-2 Pathway.长链非编码RNA MIR503HG通过靶向miR-503-5p/Bcl-2通路促进高糖诱导的近端肾小管细胞凋亡。
Diabetes Metab Syndr Obes. 2020 Nov 20;13:4507-4517. doi: 10.2147/DMSO.S277869. eCollection 2020.
7
Targeting of KDM5A by miR-421 in Human Ovarian Cancer Suppresses the Progression of Ovarian Cancer Cells.miR-421靶向KDM5A在人卵巢癌中抑制卵巢癌细胞的进展。
Onco Targets Ther. 2020 Sep 23;13:9419-9428. doi: 10.2147/OTT.S266211. eCollection 2020.
8
LINC00460 Enhances Bladder Carcinoma Cell Proliferation and Migration by Modulating miR-612/FOXK1 Axis.LINC00460 通过调节 miR-612/FOXK1 轴促进膀胱癌细胞增殖和迁移。
Pharmacology. 2021;106(1-2):79-90. doi: 10.1159/000509255. Epub 2020 Oct 7.
9
Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients.DNMT3A 突变型急性髓系白血病患者的生存差异及相关分子特征。
Sci Rep. 2020 Jul 29;10(1):12761. doi: 10.1038/s41598-020-69691-8.
10
NEAT1 Decreasing Suppresses Parkinson's Disease Progression via Acting as miR-1301-3p Sponge.NEAT1 通过作为 miR-1301-3p 的海绵体来抑制帕金森病的进展。
J Mol Neurosci. 2021 Feb;71(2):369-378. doi: 10.1007/s12031-020-01660-2. Epub 2020 Jul 25.